FDA
-
-
-
-
-
-
-
CASI Pharmaceuticals secures up to $20 million convertible note financing
-
-
-
-
-
-
-
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
-
-
-
-
-
-
-
CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
-
-
-
-
-
-
-
CASI Pharmaceuticals names David Cory as new CEO
-
-
-
-
-
-
-
CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement
-
-
-
-
-
-
-
CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia
-
-
-
-
-
-
-
CASI Pharma (CASI) Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

